BRENNA YOUNG: Open Payments
NPI 1346828845 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 21 payments from 14 companies in 2025. Trend: 2023 $1,393 · 2024 $592 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $56 |
| Abbott Laboratories | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Corcept Therapeutics | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Boston Scientific Corporation | 1 | $23 |
| IBSA Pharma Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $22 |
Products named: VRAYLAR, Belbuca, CAPLYTA, ETERNA, Korlym, TRELEGY ELLIPTA, WATCHMAN Access System, Tirosint.
Industry payments across TX — which companies pay providers there.
